These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27860166)

  • 21. Novel use of topical dapsone 5% gel for erythema elevatum diutinum: safer and effective.
    Frieling GW; Williams NL; Lim SJ; Rosenthal SI
    J Drugs Dermatol; 2013 Apr; 12(4):481-4. PubMed ID: 23652900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed pressure urticaria - dapsone heading for first-line therapy?
    Grundmann SA; Kiefer S; Luger TA; Brehler R
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):908-12. PubMed ID: 21771275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of corticosteroids in management of Herpes associated Erythema Multiforme.
    AlFar MY; AlRousan M; Almajali Z; Batarseh E; Alsaddi R
    J Pak Med Assoc; 2015 Dec; 65(12):1351-3. PubMed ID: 26627523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse reactions associated with dapsone therapy in HIV-positive patients: a case presentation and review.
    Stroup JS; Stephens JR; Reust R; Miller JA
    AIDS Read; 2006 Jan; 16(1):47-8, 53-5; discussion 54-5. PubMed ID: 16433472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
    Handler MZ; Hamilton H; Aires D
    J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices.
    Kechichian E; Ingen-Housz-Oro S; Sbidian E; Hemery F; Bernier C; Fite C; Delaunay J; Staumont-Sallé D; Toukal F; Dupin N; Abasq C; Samimi M; Picard C; Hebert V; Prost C; Monfort JB; Milpied B; Wolkenstein P; Chosidow O
    Br J Dermatol; 2018 Oct; 179(4):1009-1011. PubMed ID: 29957881
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous involvement of dermatomyositis can respond to Dapsone therapy.
    Cohen JB
    Int J Dermatol; 2002 Mar; 41(3):182-4. PubMed ID: 12010348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What do we know today about diaminodiphenylsulfone?].
    Golusin Z; Poljacki M; Preveden R; Stojanović S; Rajić N
    Med Pregl; 2000; 53(7-8):369-72. PubMed ID: 11214480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone.
    Holtzer CD; Flaherty JF; Coleman RL
    Pharmacotherapy; 1998; 18(4):831-5. PubMed ID: 9692656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent erythema multiforme in a child.
    Chan LY; Tang WY; Leung CY; Lo KK
    Hong Kong Med J; 2000 Sep; 6(3):331. PubMed ID: 11025858
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrent erythema multiforme.
    Levin J; Hofstra T
    JAMA; 2014 Jul 23-30; 312(4):426-7. PubMed ID: 25038360
    [No Abstract]   [Full Text] [Related]  

  • 33. Herpes simplex virus-induced recurrent erythema multiforme.
    Cohen PR
    J Gt Houst Dent Soc; 1995; 66(9):17-8. PubMed ID: 9594805
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
    Tanghetti E; Harper JC; Oefelein MG
    J Drugs Dermatol; 2012 Dec; 11(12):1417-21. PubMed ID: 23377510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme.
    Bakis S; Zagarella S
    Australas J Dermatol; 2005 Feb; 46(1):18-20. PubMed ID: 15670172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone.
    Vas A; Laws P; Marsland A; McQuillan O
    Int J STD AIDS; 2013 Sep; 24(9):745-7. PubMed ID: 24026795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular Contact Reaction May Progress into Erythema Multiforme.
    Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic atrophic polychondritis. Critical analysis of the therapeutic efficacy of dapsone. 2 cases].
    Gouet D; Marechaud R; Neau JP; Abadie JC; Rossi F; Sudre Y
    Presse Med; 1984 Mar; 13(12):723-6. PubMed ID: 6231576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythema multiforme presenting as chronic oral ulceration due to unrecognised herpes simplex virus infection.
    Sinha A; Chander J; Natarajan S
    Clin Exp Dermatol; 2006 Sep; 31(5):737-8. PubMed ID: 16901331
    [No Abstract]   [Full Text] [Related]  

  • 40. Herpes simplex-associated erythema multiforme (HAEM): a clinical therapeutic dilemma.
    Katz J; Livneh A; Shemer J; Danon YL; Peretz B
    Pediatr Dent; 1999; 21(6):359-62. PubMed ID: 10509338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.